Since we have previously shown that IL-4 is able to revert the IL-12-mediated transdifferentiation of ILC2s into ILC1s22, we investigated whether the absence of IL-4 alters the ILC composition in NP of CF patients. Here, IL4 is linked to cystic fibrosis.